Tag Archives: GlobalData

Investors pour $76 million into B round for Cortexyme’s “new” approach to Alzheimer’s. No, it doesn’t target Amyloid beta (Aβ); it’s bacterial and getting support from Pfizer, Paul Allen.

      No Comments on Investors pour $76 million into B round for Cortexyme’s “new” approach to Alzheimer’s. No, it doesn’t target Amyloid beta (Aβ); it’s bacterial and getting support from Pfizer, Paul Allen.

The News: With the evidence increasingly weighing in against amyloid beta as the best solo target for Alzheimer’s, startup Cortexyme Inc. (South San Francisco) has identified a brand-new target and… Read more »

Boomer Alert: Aging immune cells increase risk for macular degeneration, blindness. Apellis, Ophthotech to the rescue?

      No Comments on Boomer Alert: Aging immune cells increase risk for macular degeneration, blindness. Apellis, Ophthotech to the rescue?

The News: As people age, so do their immune systems. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk… Read more »

Micro biotech Alzinova, hiding out in southwest Sweden, using proprietary peptide technology that targets key Alzheimer’s toxins.

      No Comments on Micro biotech Alzinova, hiding out in southwest Sweden, using proprietary peptide technology that targets key Alzheimer’s toxins.

Background: Alzinova AB (Gothenburg) is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disease (AD). The company was founded in 2011… Read more »